KR20200088005A - Oil-in-water cosmetic composition of gel form with phase transfer characteristics - Google Patents
Oil-in-water cosmetic composition of gel form with phase transfer characteristics Download PDFInfo
- Publication number
- KR20200088005A KR20200088005A KR1020190004462A KR20190004462A KR20200088005A KR 20200088005 A KR20200088005 A KR 20200088005A KR 1020190004462 A KR1020190004462 A KR 1020190004462A KR 20190004462 A KR20190004462 A KR 20190004462A KR 20200088005 A KR20200088005 A KR 20200088005A
- Authority
- KR
- South Korea
- Prior art keywords
- oil
- peg
- hlb
- gel formulation
- cosmetic composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 119
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 33
- 239000002537 cosmetic Substances 0.000 title claims abstract description 29
- 238000009472 formulation Methods 0.000 claims abstract description 58
- 239000012071 phase Substances 0.000 claims abstract description 45
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 41
- 230000007704 transition Effects 0.000 claims abstract description 38
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 21
- 239000000194 fatty acid Substances 0.000 claims abstract description 21
- 229930195729 fatty acid Natural products 0.000 claims abstract description 21
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 17
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 14
- 238000010521 absorption reaction Methods 0.000 claims abstract description 14
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 14
- 150000002430 hydrocarbons Chemical class 0.000 claims abstract description 14
- 239000007791 liquid phase Substances 0.000 claims abstract description 8
- 239000003921 oil Substances 0.000 claims description 37
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 14
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 14
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 14
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 13
- 235000021355 Stearic acid Nutrition 0.000 claims description 12
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 12
- 239000008117 stearic acid Substances 0.000 claims description 12
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical group CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 11
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 10
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 10
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 10
- 229940068977 polysorbate 20 Drugs 0.000 claims description 10
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 7
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims description 6
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 claims description 6
- 229940008099 dimethicone Drugs 0.000 claims description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 claims description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 4
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 3
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims description 3
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 claims description 3
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 claims description 3
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 3
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 claims description 3
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 claims description 3
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims description 3
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 239000001587 sorbitan monostearate Substances 0.000 claims description 3
- 235000011076 sorbitan monostearate Nutrition 0.000 claims description 3
- 229940035048 sorbitan monostearate Drugs 0.000 claims description 3
- 229940031439 squalene Drugs 0.000 claims description 3
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 2
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 claims description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 claims description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 claims description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 2
- 229910052582 BN Inorganic materials 0.000 claims description 2
- 235000021357 Behenic acid Nutrition 0.000 claims description 2
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 claims description 2
- 239000005639 Lauric acid Substances 0.000 claims description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 2
- 239000004677 Nylon Substances 0.000 claims description 2
- 239000005642 Oleic acid Substances 0.000 claims description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000021314 Palmitic acid Nutrition 0.000 claims description 2
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 claims description 2
- 229920001219 Polysorbate 40 Polymers 0.000 claims description 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 2
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 claims description 2
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 claims description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 2
- 229940116226 behenic acid Drugs 0.000 claims description 2
- 229940094978 bis-peg-18 methyl ether dimethyl silane Drugs 0.000 claims description 2
- 229940073669 ceteareth 20 Drugs 0.000 claims description 2
- 229940073642 ceteareth-30 Drugs 0.000 claims description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 claims description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- ANXXYABAFAQBOT-UHFFFAOYSA-N dodecyl-methyl-bis(trimethylsilyloxy)silane Chemical compound CCCCCCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C ANXXYABAFAQBOT-UHFFFAOYSA-N 0.000 claims description 2
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 claims description 2
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 claims description 2
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 claims description 2
- 229940074052 glyceryl isostearate Drugs 0.000 claims description 2
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 2
- 235000020778 linoleic acid Nutrition 0.000 claims description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 2
- 229960004488 linolenic acid Drugs 0.000 claims description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- 229920001778 nylon Polymers 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 235000021313 oleic acid Nutrition 0.000 claims description 2
- 229940100460 peg-100 stearate Drugs 0.000 claims description 2
- 229940016593 peg-20 glyceryl isostearate Drugs 0.000 claims description 2
- 229940032067 peg-20 stearate Drugs 0.000 claims description 2
- 229940031709 peg-30-dipolyhydroxystearate Drugs 0.000 claims description 2
- 229940023750 peg-60 glyceryl isostearate Drugs 0.000 claims description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 claims description 2
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 claims description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims description 2
- 229940101027 polysorbate 40 Drugs 0.000 claims description 2
- 229940113124 polysorbate 60 Drugs 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- 229940068968 polysorbate 80 Drugs 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 229920002379 silicone rubber Polymers 0.000 claims description 2
- 229940057429 sorbitan isostearate Drugs 0.000 claims description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 claims description 2
- 239000001589 sorbitan tristearate Substances 0.000 claims description 2
- 235000011078 sorbitan tristearate Nutrition 0.000 claims description 2
- 229960004129 sorbitan tristearate Drugs 0.000 claims description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 2
- 239000011787 zinc oxide Substances 0.000 claims description 2
- 239000004711 α-olefin Substances 0.000 claims description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims 1
- 229940032094 squalane Drugs 0.000 claims 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims 1
- 230000003020 moisturizing effect Effects 0.000 abstract description 7
- 239000007788 liquid Substances 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract 4
- 239000000499 gel Substances 0.000 description 36
- 230000000694 effects Effects 0.000 description 30
- 230000000052 comparative effect Effects 0.000 description 29
- 210000003491 skin Anatomy 0.000 description 19
- 238000012360 testing method Methods 0.000 description 15
- 229950011392 sorbitan stearate Drugs 0.000 description 8
- 239000007764 o/w emulsion Substances 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- -1 for example Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000004815 dispersion polymer Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
본 발명은 상전이 성질을 갖는 젤 제형의 수중유형 화장료 조성물에 관한 것이다.The present invention relates to an oil-in-water cosmetic composition of a gel formulation having a phase change property.
일반적으로, 유성 성분은, 화장료 등의 피부 외용제에 피부 보습을 목적으로 배합된다. 이러한 유성 성분을 다량으로 배합한 에멀젼, 크림 등의 수중유형의 기존 유화제품은 안정도가 우수하고 높은 피부 보습감을 나타내나 점도가 높아 발림성이 좋지 않으며, 특유의 끈적함과 잔여감으로 인하여 좋지 않은 사용감을 나타낼 수 있다.In general, the oily component is blended in a skin external preparation such as a cosmetic for the purpose of moisturizing the skin. Existing emulsified products of oil-in-water type, such as emulsions and creams, which are formulated with a large amount of these oily ingredients, have excellent stability and high skin moisturizing properties, but have high viscosity and poor spreadability, and have a poor feeling of use due to the unique stickiness and residual feeling. Can be represented.
산뜻한 사용감을 나타내는 투명한 화장수 등의 가용화 제형의 화장료 조성물의 경우에는, 통상적으로 유화제의 가용화 성능을 사용하여 유성 성분을 배합하기 때문에, 다량의 유성 성분을 배합하기 어렵고 따라서 일반적으로 유성 성분에 의한 보습 효과가 떨어지는 단점이 있다.In the case of a cosmetic composition of a solubilizing formulation such as transparent lotion that exhibits a fresh feeling of use, since an oily component is usually blended using the solubilizing performance of an emulsifier, it is difficult to blend a large amount of oily components, and thus, the moisturizing effect of the oily component is generally used. It has the disadvantage of falling.
한편, 유중수형의 유화제품에는 친수성이 높은 유화제를 사용하는데, 이들 유화제는 피부에 잔존해 있다가 세안 시 피부 보습을 담당하는 각질층의 손상을 유발시킬 가능성이 있다는 단점이 있다.On the other hand, water-in-oil type emulsifiers use emulsifiers with high hydrophilicity, and these emulsifiers have the disadvantage that they remain on the skin and may cause damage to the stratum corneum responsible for moisturizing the skin when washing.
또한, 기존의 유중수형(water-in-oil) 유화 제형, 수중유형(oil-in-water) 유화 제형, 수분산 젤형 등의 경우에는 과도한 유화제 또는 수분산 고분자에 의해 효과적인 상전이 효과를 나타내기 어려우며, 특히, 수분산 젤형은 오일을 사용하지 않기 때문에 피부 잔여감은 거의 없으나 보습 효과 또한 낮다는 단점이 있다.In addition, in the case of the existing water-in-oil emulsion formulation, oil-in-water emulsion formulation, and water-dispersion gel type, it is difficult to exhibit an effective phase transition effect by excessive emulsifier or water-dispersion polymer. , In particular, since the water-dispersion gel type does not use oil, there is almost no residual feeling of skin, but the moisturizing effect is also low.
상기한 문제점을 해결하기 위하여, 본 발명은 피부에 도포 시 피부 온도에 의해 고점도의 젤 제형에서 액체로 상전이가 발생되는 젤 제형의 수중유형 화장료 조성물을 제공하는 것을 목적으로 한다.In order to solve the above problems, an object of the present invention is to provide an oil-in-water cosmetic composition of a gel formulation in which a phase transition from a high-viscosity gel formulation to a liquid occurs when applied to the skin.
또한, 본 발명은 고점도 젤 제형으로서 발림성이 좋고 빠른 상전이 효과로 인하여 물이 휘발된 후에는 강한 밀착감과 보송한 마무리감을 가지고 있어 사용감이 우수하며, 유화제형의 안정도 또한 뛰어난 수중유형 화장료 조성물을 제공하는 것을 목적으로 한다.In addition, the present invention is a high-viscosity gel formulation, which has excellent spreadability and has a strong feeling of adhesion and smooth finish after volatilization of water due to a fast phase change effect, thereby providing an oil-in-water cosmetic composition excellent in stability of the emulsifying agent and also having excellent stability. It is aimed at.
상기한 목적을 달성하기 위하여, 본 발명의 일 실시예는 지방산; 하이드로카본계 오일; HLB가 3 내지 6인 유화제; HLB가 10 내지 18인 유화제; 및 흡유 파우더를 함유하고,In order to achieve the above object, an embodiment of the present invention is a fatty acid; Hydrocarbon-based oils; Emulsifiers with HLB of 3 to 6; Emulsifier with HLB of 10 to 18; And oil absorption powder,
피부에 도포 시 젤상(gel phase)에서 액상(liquid phase)으로의 상전이 성질을 지니는, 젤 제형의 수중유형 화장료 조성물을 제공한다.Provided is an oil-in-water cosmetic composition of a gel formulation having a phase transition property from a gel phase to a liquid phase when applied to the skin.
본 발명에 의한 젤 제형의 수중유형 화장료 조성물은 HLB가 3 내지 6인 w/o형 유화제와 HLB가 10 내지 18인 o/w형 유화제를 동시에 함유함으로써, 피부에 도포 시 젤 제형에서 액체로의 빠른 상전이감으로 인하여 물이 휘발된 후 강한 밀착감과 보송한 마무리감을 가지고 있어 사용감이 우수하다.The oil-in-water cosmetic composition of the gel formulation according to the present invention contains a w/o emulsifier having an HLB of 3 to 6 and an o/w emulsifier having an HLB of 10 to 18 at the same time, from a gel formulation to a liquid when applied to the skin. Because of the fast phase transition, after water volatilization, it has a strong adhesion and a soft finish, so it is excellent in use.
또한, 본 발명에 의한 젤 제형의 수중유형 화장료 조성물은 고점도의 젤 제형으로 인하여 발림성이 좋고 오일 성분이 안정적으로 유화됨으로써 피부 보습감 또한 우수하다.In addition, the oil-in-water type cosmetic composition of the gel formulation according to the present invention is excellent in skin moisturizing feeling because of its high-viscosity gel formulation, which has good spreadability and stably emulsifies oil components.
도 1은 비교예 5(좌) 및 실시예 2(우)의 외관 비교 결과를 나타낸 것이다.
도 2는 실시예 2(좌) 및 비교예 10(우)의 외관 비교 결과를 나타낸 것이다.1 shows the results of appearance comparison of Comparative Example 5 (left) and Example 2 (right).
2 shows the results of appearance comparison of Example 2 (left) and Comparative Example 10 (right).
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 일 측면에서, 지방산; 하이드로카본계 오일; HLB가 3 내지 6인 유화제; HLB가 10 내지 18인 유화제; 및 흡유 파우더를 함유하고, 피부에 도포 시 젤상(gel phase)에서 액상(liquid phase)으로의 상전이 성질을 지니는, 젤 제형의 수중유형 화장료 조성물에 관한 것일 수 있다.The present invention in one aspect, fatty acids; Hydrocarbon-based oils; Emulsifiers with HLB of 3 to 6; Emulsifier with HLB of 10 to 18; And it may be related to an oil-in-water cosmetic composition of a gel formulation containing an oil absorption powder and having a phase transition property from a gel phase to a liquid phase when applied to the skin.
일 구현 예로서, 상기 지방산은 본 발명의 조성물에 있어서, 고점도의 젤을 형성하기 위해 사용되며, 예를 들어, 스테아르산(stearic acid), 팔미트산(palmitic acid), 라우르산(lauric acid), 카프로산(caproic acid), 베헨산(behenic acid) 및 이들의 조합으로부터 선택되는 1종의 포화지방산; 올레산(oleic acid), 리놀레산(linoleic acid) 및 리놀레닉산(linolenic acid) 및 이들의 조합으로부터 선택되는 1종의 불포화지방산; 및 이들의 조합으로부터 선택되는 1종 이상일 수 있으나, 이에 한정되는 것은 아니다.As an embodiment, the fatty acid is used in the composition of the present invention to form a high-viscosity gel, for example, stearic acid, palmitic acid, lauric acid ), caproic acid, behenic acid, and one saturated fatty acid selected from combinations thereof; One unsaturated fatty acid selected from oleic acid, linoleic acid and linolenic acid, and combinations thereof; And may be one or more selected from a combination of these, but is not limited thereto.
일 구현 예로서, 상기 지방산은 조성물 총 중량을 기준으로 7 내지 10 중량%의 양으로 함유될 수 있다. 상기 지방산의 함량이 7 중량% 미만이면 점도가 낮아 젤 제형이 형성되지 않거나 피부에 도포 시 액상으로의 상전이 효과가 나타나지 않을 수 있으며, 상기 지방산의 함량이 10 중량% 초과이면 피부에 도포 시 액상으로의 상전이 효과가 빠르게 나타나지 않을 수 있다.As an embodiment, the fatty acid may be contained in an amount of 7 to 10% by weight based on the total weight of the composition. When the content of the fatty acid is less than 7% by weight, the viscosity is low, so that a gel formulation may not be formed or the phase transition effect to the liquid phase may not appear when applied to the skin. If the fatty acid content is more than 10% by weight, it becomes a liquid phase when applied to the skin. The phase transition effect of may not appear quickly.
다른 구현 예로서, 상기 지방산은 조성물 총 중량을 기준으로 7 중량% 이상, 7.2 중량% 이상, 7.5 중량% 이상, 7.8 중량% 이상, 8 중량% 이상, 8.2 중량% 이상, 8.5 중량% 이상, 8.8 중량% 이상, 9 중량% 이상, 9.2 중량% 이상, 9.5 중량% 이상 또는 9.8 중량% 이상의 양으로 함유될 수 있으며, 또한, 상기 지방산은 조성물 총 중량을 기준으로 10 중량% 이하, 9.8 중량% 이하, 9.5 중량% 이하, 9.2 중량% 이하, 9 중량% 이하, 8.8 중량% 이하, 8.5 중량% 이하, 8.2 중량% 이하, 8 중량% 이하, 7.8 중량% 이하, 7.5 중량% 이하 또는 7.2 중량% 이하의 양으로 함유될 수 있다.As another embodiment, the fatty acid is 7 wt% or more, 7.2 wt% or more, 7.5 wt% or more, 7.8 wt% or more, 8 wt% or more, 8.2 wt% or more, 8.5 wt% or more, 8.8 based on the total weight of the composition More than 9% by weight, 9% by weight or more, 9.2% by weight or more, 9.5% by weight or more or 9.8% by weight or more may be contained, and the fatty acid is 10% by weight or less based on the total weight of the composition, 9.8% by weight or less , 9.5% or less, 9.2% or less, 9% or less, 8.8% or less, 8.5% or less, 8.2% or less, 8% or less, 7.8% or less, 7.5% or less or 7.2% or less It can be contained in the amount of.
또 다른 구현 예로서, 상기 지방산은 융점이 40 내지 70℃일 수 있다. 구체적으로, 상기 지방산의 융점은 40℃ 이상, 45℃ 이상, 50℃ 이상, 53℃ 이상, 55℃ 이상, 57℃ 이상, 60℃ 이상 또는 65℃ 이상일 수 있으며, 또한, 상기 지방산의 융점은 70℃ 이하, 65℃ 이하, 60℃ 이하, 57℃ 이하, 55℃ 이하 또는 53℃ 이하일 수 있다. 상기 지방산의 융점이 40℃ 미만이면, 젤 제형이 형성되지 않으며, 70℃ 초과이면, 제형이 너무 하드(hard)해져 또한 젤 제형이 형성되지 않는다. 바람직하게는, 상기 지방산의 융점은 53 내지 57℃일 수 있다.As another embodiment, the fatty acid may have a melting point of 40 to 70°C. Specifically, the melting point of the fatty acid may be 40°C or higher, 45°C or higher, 50°C or higher, 53°C or higher, 55°C or higher, 57°C or higher, 60°C or higher, or 65°C or higher, and the melting point of the fatty acid is 70 ℃ or less, 65 ℃ or less, 60 ℃ or less, 57 ℃ or less, 55 ℃ or less, or 53 ℃ or less. If the melting point of the fatty acid is less than 40°C, a gel formulation is not formed, and if it exceeds 70°C, the formulation becomes too hard and a gel formulation is not formed. Preferably, the melting point of the fatty acid may be 53 to 57 ℃.
일 구현 예로서, 상기 하이드로카본계 오일은 흡유 파우더를 분산시켜 안정적으로 젤을 형성하기 위해 사용되며, 예를 들어, C18-21 알칸(C18-21 alkane), 이소헥사데칸(isohexadecane), 이소도데칸(isododecane), 운데칸(undecane), 스쿠알란(squalan), 스쿠알렌(squalene), 하이드로제네이티드폴리데센(hydrogenated polydecene), 하이드로제네이티드폴리이소부텐(hydrogenated polyisobutene) 및 알파올레핀올리고머(alpha olefin oligomers) 중에서 선택되는 1종 이상일 수 있으나 이에 한정되는 것은 아니다.As an embodiment, the hydrocarbon-based oil is used to stably form a gel by dispersing the oil absorption powder, for example, C18-21 alkane, isohexadecane, isodo Decane, undecane, squalan, squalene, hydrogenated polydecene, hydrogenated polyisobutene and alpha olefin oligomers It may be one or more selected from, but is not limited thereto.
일 구현 예로서, 상기 하이드로카본계 오일은 조성물 총 중량을 기준으로 5 내지 9 중량%의 양으로 함유될 수 있다. 상기 하이드로카본계 오일의 함량이 5 중량% 미만이면 젤 제형이 형성되지 않으며, 상전이 효과 또한 나타나지 않을 수 있고, 상기 하이드로카본계 오일의 함량이 9 중량% 초과이면 피부에 도포 시 액상으로의 상전이 효과가 빠르게 나타나지 않을 수 있다.As an embodiment, the hydrocarbon-based oil may be contained in an amount of 5 to 9% by weight based on the total weight of the composition. If the content of the hydrocarbon-based oil is less than 5% by weight, a gel formulation is not formed, and a phase transition effect may also not be exhibited. If the content of the hydrocarbon-based oil is more than 9% by weight, a phase transition effect to a liquid phase when applied to the skin May not appear quickly.
다른 구현 예로서, 상기 하이드로카본계 오일의 함량은 조성물 총 중량을 기준으로 5 중량% 이상, 6 중량% 이상, 7 중량% 이상, 7.2 중량% 이상, 7.5 중량% 이상, 7.8 중량% 이상, 8 중량% 이상, 8.2 중량% 이상, 8.5 중량% 이상 또는 8.8 중량% 이상일 수 있으며, 또한, 상기 하이드로카본계 오일의 함량은 조성물 총 중량을 기준으로 9 중량% 이하, 8.8 중량% 이하, 8.5 중량% 이하, 8.2 중량% 이하, 8 중량% 이하, 7.8 중량% 이하, 7.5 중량% 이하, 7.2 중량% 이하, 7 중량% 이하 또는 6 중량% 이하일 수 있다.As another embodiment, the content of the hydrocarbon-based oil is 5 wt% or more, 6 wt% or more, 7 wt% or more, 7.2 wt% or more, 7.5 wt% or more, 7.8 wt% or more, 8 based on the total weight of the composition It may be at least 8% by weight, at least 8.2% by weight, at least 8.5% by weight or at least 8.8% by weight, and the content of the hydrocarbon-based oil is 9% by weight or less, 8.8% by weight or less, 8.5% by weight based on the total weight of the composition. Or less, 8.2% or less, 8% or less, 7.8% or less, 7.5% or less, 7.2% or less, 7% or less, or 6% or less.
일 구현 예로서, 상기 HLB(hydrophile-lipophile balance)가 3 내지 6인 유화제는 w/o(water-in-oil)형 유화제로서, 조성물의 피부 도포 시 빠른 상전이 효과를 위해 사용되며, 예를 들어, 소르비탄 모노스테아레이트(sorbitan monostearate), 소르비탄 이소스테아레이트(sorbitan isostearate), 소르비탄 모노이소스테아레이트(sorbitan monoisostearate), 소르비탄 트리스테아레이트(sorbitan tristearate), 소르비탄 모노라우레이트(sorbitan monolaurate), 글리세롤 모노스테아레이트(glycerol monostearate), 글리세롤 모노올레이트(glycerol monooleate), 세틸 피이지/피피지-10/1 디메치콘(cetyl PEG/PPG-10/1 dimethicone), 피이지-30 디폴리하이드록시스테아레이트(PEG-30 dipolyhydroxystearate), 라우릴 피이지/피피지-18/18 메치콘(lauryl PEG/PPG-18/18 methicone; laurylmethicone copolyol) 및 피이지-10 디메치콘(PEG-10 dimethicone) 중에서 선택되는 1종 이상일 수 있으나, 이에 한정되는 것은 아니다.As an embodiment, the emulsifier having a hydrophile-lipophile balance (HLB) of 3 to 6 is a w/o (water-in-oil) emulsifier, which is used for a rapid phase change effect when applying the composition to the skin, for example , Sorbitan monostearate, sorbitan isostearate, sorbitan monoisostearate, sorbitan tristearate, sorbitan monolaurate ), glycerol monostearate, glycerol monooleate, cetyl PEG/fiji-10/1 dimethicone, PEG-30 dipoly PEG-30 dipolyhydroxystearate, lauryl PEG/PPG-18/18 methicone; laurylmethicone copolyol and PEG-10 dimethicone ) May be one or more selected from, but is not limited thereto.
일 구현 예로서, 상기 HLB가 3 내지 6인 유화제는 조성물 총 중량을 기준으로 3 내지 5 중량%의 양으로 함유될 수 있다. 상기 HLB가 3 내지 6인 유화제의 함량이 3 중량% 미만이거나 5 중량% 초과이면, 제형이 분리되어 목적하는 상전이 효과를 나타낼 수 없다.As an exemplary embodiment, the emulsifier having HLB of 3 to 6 may be contained in an amount of 3 to 5% by weight based on the total weight of the composition. When the content of the emulsifier having HLB of 3 to 6 is less than 3% by weight or more than 5% by weight, the formulation may be separated and exhibit a desired phase transition effect.
다른 구현 예로서, 상기 HLB가 3 내지 6인 유화제의 함량은 조성물 총 중량을 기준으로 3 중량% 이상, 3.1 중량% 이상, 3.2 중량% 이상, 3.3 중량% 이상, 3.4 중량% 이상, 3.5 중량% 이상, 3.6 중량% 이상, 3.7 중량% 이상, 3.8 중량% 이상, 3.9 중량% 이상, 4 중량% 이상, 4.3 중량% 이상, 4.5 중량% 이상 또는 4.7 중량% 이상일 수 있으며, 또한, 5 중량% 이하, 4.7 중량% 이하, 4.5 중량% 이하, 4.3 중량% 이하, 4 중량% 이하, 3.9 중량% 이하, 3.8 중량% 이하, 3.7 중량% 이하, 3.6 중량% 이하, 3.5 중량% 이하, 3.4 중량% 이하, 3.3 중량% 이하 또는 3.2 중량% 이하일 수 있다.As another embodiment, the content of the emulsifier having HLB of 3 to 6 is 3% by weight or more, 3.1% by weight or more, 3.2% by weight or more, 3.3% by weight or more, 3.4% by weight or more, and 3.5% by weight based on the total weight of the composition. Or more, 3.6% or more, 3.7% or more, 3.8% or more, 3.9% or more, 4% or more, 4.3% or more, 4.5% or more, or 4.7% or more, and 5% or less , 4.7% or less, 4.5% or less, 4.3% or less, 4% or less, 3.9% or less, 3.8% or less, 3.7% or less, 3.6% or less, 3.5% or less, 3.4% or less , 3.3% by weight or less or 3.2% by weight or less.
일 구현 예로서, 상기 HLB가 10 내지 18인 유화제는 o/w(oil-in-water)형 유화제로서, 조성물의 피부 도포 시 빠른 상전이 효과를 위해 상기 HLB가 3 내지 6인 w/o형 유화제와 함께 사용되며, 예를 들어, 세테아레스-12(ceteareth-12), 세테아레스-20(ceteareth-20), 세테아레스-25(ceteareth-25), 세테아레스-30(ceteareth-30), 피이지-20 스테아레이트(PEG-20 stearate), 피이지-30 스테아레이트(PEG-30 stearate), 피이지-40 스테아레이트(PEG-40 stearate), 피이지-100 스테아레이트(PEG-100 stearate), 폴리소르베이트 20(polysorbate 20), 폴리소르베이트 40(polysorbate 40), 폴리소르베이트 60(polysorbate 60), 폴리소르베이트 80(polysorbate 80), 피이지-20 글리세릴 이소스테아레이트(PEG-20 glyceryl isostearate), 피이지-60 글리세릴 이소스테아레이트(PEG-60 glyceryl isostearate) 및 비스-피이지-18 메틸 에테르 디메틸 실란(bis-PEG-18 methyl ether dimethyl silane) 중에서 선택되는 1종 이상일 수 있다.As an embodiment, the emulsifier having an HLB of 10 to 18 is an oil-in-water (o/w) emulsifier, and the w/o emulsifier having an HLB of 3 to 6 for rapid phase transition effect when the composition is applied to the skin. Used with, for example, ceteareth-12, ceteareth-20, ceteareth-25, ceteareth-30, p PEG-20 stearate, PEG-30 stearate, PEG-40 stearate, PEG-100 stearate , Polysorbate 20, polysorbate 40, polysorbate 60, polysorbate 80, PEG-20 glyceryl isostearate (PEG-20 It may be at least one selected from glyceryl isostearate, PEG-60 glyceryl isostearate, and bis-PEG-18 methyl ether dimethyl silane. .
일 구현 예로서, 상기 HLB가 10 내지 18인 유화제는 조성물 총 중량을 기준으로 3 내지 5 중량%의 양으로 함유될 수 있다. 상기 HLB가 10 내지 18인 유화제의 함량이 3 중량% 미만이거나 5 중량% 초과이면, 제형이 분리되어 목적하는 상전이 효과를 나타낼 수 없다.As an exemplary embodiment, the emulsifier having HLB of 10 to 18 may be contained in an amount of 3 to 5% by weight based on the total weight of the composition. When the content of the emulsifier having the HLB of 10 to 18 is less than 3% by weight or more than 5% by weight, the formulation may be separated and exhibit a desired phase transition effect.
다른 구현 예로서, 상기 HLB가 10 내지 18인 유화제의 함량은 조성물 총 중량을 기준으로 3 중량% 이상, 3.3 중량% 이상, 3.5 중량% 이상, 3.7 중량% 이상, 4 중량% 이상, 4.3 중량% 이상, 4.5 중량% 이상 또는 4.7 중량% 이상일 수 있으며, 또한, 5 중량% 이하, 4.7 중량% 이하, 4.5 중량% 이하, 4.3 중량% 이하, 4 중량% 이하, 3.7 중량% 이하, 3.5 중량% 이하 또는 3.3 중량% 이하일 수 있다.As another embodiment, the content of the emulsifier having HLB of 10 to 18 is 3% by weight or more, 3.3% by weight or more, 3.5% by weight or more, 3.7% by weight or more, 4% by weight or more, 4.3% by weight based on the total weight of the composition. Or more, 4.5% or more, or 4.7% or more, and 5% or less, 4.7% or less, 4.5% or less, 4.3% or less, 4% or less, 3.7% or less, 3.5% or less Or 3.3% by weight or less.
또 다른 구현 예로서, 목적하는 효과를 위하여, 상기 HLB가 3 내지 6인 유화제 및 상기 HLB가 10 내지 18인 유화제는 중량비 3 내지 4 : 3 내지 5로 함유될 수 있다.As another embodiment, for the desired effect, the emulsifier with HLB of 3 to 6 and the emulsifier with HLB of 10 to 18 may be contained in a weight ratio of 3 to 4:3 to 5.
일 구현 예로서, 상기 흡유 파우더는 오일을 흡유하여 빠른 상전이 효과를 나타내기 위하여 사용되며, 예를 들어, 폴리메틸메타크릴레이트(polymethyl methacrylate, PMMA), 실리카, 나일론 파우더, 보론 나이트라이드 파우더, 티타늄 옥사이드, 징크 옥사이드 및 실리콘 엘라스토머 중에서 선택되는 1종 이상일 수 있으나, 이에 한정되는 것은 아니다.As an exemplary embodiment, the oil absorption powder is used to show a rapid phase transition effect by absorbing oil, for example, polymethyl methacrylate (PMMA), silica, nylon powder, boron nitride powder, titanium It may be one or more selected from oxide, zinc oxide, and silicone elastomer, but is not limited thereto.
일 구현 예로서, 상기 흡유 파우더는 조성물 총 중량을 기준으로 17 내지 25 중량%의 양으로 함유될 수 있다. 상기 흡유 파우더의 함량이 17 중량% 미만이거나 25 중량% 초과이면 오일 흡유가 잘 되지 않거나 너무 많이 흡유되어 목적하는 상전이 효과를 나타낼 수 없다.As an embodiment, the oil absorption powder may be contained in an amount of 17 to 25% by weight based on the total weight of the composition. If the content of the oil absorption powder is less than 17% by weight or more than 25% by weight, oil absorption is not good or too much oil is absorbed, so that the desired phase transition effect cannot be exhibited.
일 구현 예로서, 상기 조성물은 젤 제형으로서, 점도가 45,000 내지 75,000 cps일 수 있다. 구체적으로, 상기 조성물의 점도는 45,000 cps 이상, 47,000 cps 이상, 49,000 cps 이상, 53,000 cps 이상, 57,000 cps 이상, 61,000 cps 이상, 63,000 cps 이상, 66,000 cps 이상 또는 70,000 cps 이상일 수 있으며, 또한, 75,000 cps 이하, 7,0000 cps 이하, 66,000 cps 이하, 63,000 cps 이하, 61,000 cps 이하, 57,000 cps 이하, 53,000 cps 이하, 49,000 cps 이하 또는 47,000 cps 이하일 수 있다. 바람직하게는 상기 조성물의 점도는 57,000 내지 63,000 cps 일 수 있다.In one embodiment, the composition is a gel formulation, and may have a viscosity of 45,000 to 75,000 cps. Specifically, the viscosity of the composition may be 45,000 cps or more, 47,000 cps or more, 49,000 cps or more, 53,000 cps or more, 57,000 cps or more, 61,000 cps or more, 63,000 cps or more, 66,000 cps or more, or 70,000 cps or more, and 75,000 cps or more Hereinafter, it may be 70000 cps or less, 66,000 cps or less, 63,000 cps or less, 61,000 cps or less, 57,000 cps or less, 53,000 cps or less, 49,000 cps or less, or 47,000 cps or less. Preferably, the viscosity of the composition may be 57,000 to 63,000 cps.
본 발명의 일 측면에 따른 상기 화장료 조성물은 필요에 따라 일반적인 화장료 조성물에 포함되는 성분이 추가로 배합될 수 있다. 이외에 포함되는 배합 성분으로는 보습제, 유기 및 무기 안료, 자외선 흡수제, 방부제, 살균제, 산화 방지제, 봉쇄제, 식물 추출물, pH 조절제, 색소, 향료, 냉감제, 정제수 등을 들 수 있다.The cosmetic composition according to an aspect of the present invention may be further added to the components included in the general cosmetic composition, if necessary. Other ingredients included include moisturizers, organic and inorganic pigments, ultraviolet absorbers, preservatives, fungicides, antioxidants, blockers, plant extracts, pH adjusters, pigments, flavors, coolants, and purified water.
이하, 본 발명의 내용을 실시예 및 시험예를 통하여 보다 구체적으로 설명한다. 그러나, 이러한 실시예 및 시험예는 본 발명의 내용을 이해하기 위해 제시되는 것일 뿐, 본 발명의 권리범위가 이러한 실시예 및 시험예로 한정되는 것은 아니고, 당업계에서 통상적으로 주지된 변형, 치환 및 삽입 등을 수행할 수 있으며, 이에 대한 것도 본 발명의 범위에 포함된다.Hereinafter, the contents of the present invention will be described in more detail through examples and test examples. However, these examples and test examples are only presented to understand the contents of the present invention, the scope of the present invention is not limited to these examples and test examples, and modifications and substitutions commonly known in the art And insertion, and the like is also included in the scope of the present invention.
[시험예 1] 지방산 함량에 따른 점도, 젤 형성 및 상전이 효과 평가[Test Example 1] Evaluation of viscosity, gel formation and phase transition effect according to fatty acid content
하기 표 1에 따른 조성으로 수중유형 조성물을 하기와 같은 방법으로 제조하였다:The oil-in-water composition with the composition according to Table 1 was prepared by the following method:
스테아르산(stearic acid), C18-22 알칸(C18-22 alkane), 소르비탄 스테아레이트(sorbitan stearate) 및 폴리소르베이트(polysorbate 20)을 각각 하기 표 1에 제시된 양으로 비커에 넣고 60℃로 가온한 후 호모믹서(T.K. Homo Mixer Mark II, PRIMIX 社)를 작동시키면서 폴리메틸메타크릴레이트(PMMA)를 첨가하여 분산시켰다. 그 다음 60℃로 가온한 물을 넣고 분산시킨 다음 상온으로 냉각시켜 젤 제형의 수중유형 조성물을 얻었다.Stearic acid, C18-22 alkane, sorbitan stearate and polysorbate 20 were placed in a beaker in the amounts shown in Table 1 below and heated to 60°C. Then, while operating a homomixer (TK Homo Mixer Mark II, PRIMIX Co.), polymethyl methacrylate (PMMA) was added and dispersed. Then, water heated to 60° C. was added and dispersed, and then cooled to room temperature to obtain an oil-in-water composition of a gel formulation.
조성물의 점도는 상온으로 식힌 후의 점도를 측정하였고, Brookfield 사의 Dv-III Ulatra Rheometer를 사용하여 측정하였으며, 측정된 점도가 45,000cps 미만일 경우에는 젤이 형성되지 않는 것으로 평가하였다.The viscosity of the composition was measured after cooling to room temperature, and measured using a Dv-III Ulatra Rheometer manufactured by Brookfield, and the gel was not formed when the measured viscosity was less than 45,000 cps.
조성물의 상전이 효과는 피부 표면의 온도인 34 내지 35℃와 비슷한 조건인 35℃의 항온조에 각각의 조성물을 1주일 동안 넣어둔 후 점도를 측정하여 25℃에서의 점도 대비 50% 이상 점도가 감소할 경우 상전이 효과가 좋은 것으로 평가하였다. 즉, 점도가 50% 이상 감소하면 상전이 효과가 좋은 것(O)으로, 점도가 50% 미만으로 감소하면 상전이 효과가 좋지 않은 것(X)으로 평가하였다.The phase transition effect of the composition is reduced by 50% or more compared to the viscosity at 25° C. by measuring the viscosity after placing each composition in a constant temperature bath at 35° C., which is a condition similar to 34 to 35° C., the temperature of the skin surface. In this case, it was evaluated that the phase transition effect was good. That is, when the viscosity decreases by 50% or more, the phase transition effect is good (O), and when the viscosity decreases to less than 50%, the phase transition effect is evaluated as poor (X).
그 결과는 하기 표 1에 나타내었다.The results are shown in Table 1 below.
상기 표 1의 결과로부터, 본 발명에 따라 지방산(스테아르산)을 7 내지 10 중량%로 포함하는 실시예 1 내지 3의 경우, 57,000 내지 61,000 cps 범위 내에서 점도가 형성되어 젤이 안정적으로 형성되며, 피부에 도포 시 젤상에서 빠르게 액상으로 상전이가 발생하는 것을 확인할 수 있었다.From the results of Table 1, in the case of Examples 1 to 3 containing 7 to 10% by weight of fatty acids (stearic acid) according to the present invention, the viscosity is formed within the range of 57,000 to 61,000 cps and the gel is stably formed. , When applied to the skin, it was confirmed that the phase transition occurs in a liquid phase rapidly on the gel.
반면, 스테아르산을 포함하지 않는 비교예 1의 경우, 점도가 너무 낮아 젤이 형성되지 않으며 이에 따라 상전이 효과 또한 나타나지 않음을 확인할 수 있었다. 또한, 스테아르산을 각각 5 중량% 및 11 중량%로 포함하는 비교예 2 및 3의 경우에는 젤은 형성되었으나, 상전이가 잘 이루어지지 않는 것을 확인할 수 있었다.On the other hand, in Comparative Example 1, which does not contain stearic acid, it was confirmed that the gel was not formed because the viscosity was too low, and thus the phase transition effect was also not observed. In addition, in the case of Comparative Examples 2 and 3 containing stearic acid at 5% by weight and 11% by weight, respectively, gels were formed, but it was confirmed that phase transition was not well achieved.
[시험예 2] 하이드로카본계 오일 함량에 따른 점도, 젤 형성 및 상전이 효과 평가[Test Example 2] Evaluation of viscosity, gel formation and phase transition effect according to the content of hydrocarbon-based oil
하기 표 2에 따른 조성의 수중유형 조성물을 상기 시험예 1과 동일한 방법으로 제조하고, 상기 시험예 1에서와 동일한 방법으로 점도, 젤 형성 및 상전이 효과를 평가하였다. 그 결과는 하기 표 2에 나타내었다.An oil-in-water composition of the composition according to Table 2 was prepared in the same manner as in Test Example 1, and the viscosity, gel formation, and phase transition effects were evaluated in the same manner as in Test Example 1. The results are shown in Table 2 below.
상기 표 2의 결과로부터, 본 발명에 따라 하이드로카본계 오일(C18-21 알칸)을 7 내지 9 중량%로 포함하는 실시예 2, 4 및 5의 경우, 58,000 내지 60,000 cps 범위 내에서 점도가 형성되어 젤이 안정적으로 형성되며, 피부에 도포 시 젤상에서 빠르게 액상으로 상전이가 발생하는 것을 확인할 수 있었다.From the results of Table 2, in the case of Examples 2, 4 and 5 containing 7 to 9% by weight of a hydrocarbon-based oil (C18-21 alkane) according to the present invention, the viscosity is formed within the range of 58,000 to 60,000 cps It was confirmed that the gel is stably formed, and when it is applied to the skin, a phase transition occurs in a liquid form on the gel rapidly.
반면, C18-21 알칸 오일을 포함하지 않거나 3 중량%로 포함하는 비교예 4 및 5의 경우, 제형이 형성되지 않아 점도 측정이 불가하였으며, 이에 따라 상전이 효과 또한 나타나지 않음을 확인할 수 있었다. 또한, C18-21 알칸 오일을 10 중량%로 포함하는 비교예 6의 경우에는 젤은 형성되었으나, 상전이가 잘 이루어지지 않는 것을 확인할 수 있었다.On the other hand, in Comparative Examples 4 and 5, which did not contain C18-21 alkane oil or contained in 3% by weight, it was confirmed that the viscosity was not measured because the formulation was not formed, and accordingly, the phase transition effect was also not observed. In addition, in the case of Comparative Example 6 containing 10% by weight of C18-21 alkane oil, the gel was formed, it was confirmed that the phase transition is not well made.
또한, 도 1은 실시예 2 및 비교예 5의 외관 비교 결과를 나타낸 것으로서, 도 1로부터, C18-21 알칸 오일을 3 중량%로 포함하는 비교예 5(왼쪽)의 경우 지방산 성분(stearic acid)이 알갱이로 석출되어 제형이 만들어지지 않는 것을 육안으로 확인할 수 있으며, 반면 본 발명에 따른 실시예 2(오른쪽)의 경우 파우더 성분이 석출됨이 없이 안정적으로 젤 제형이 형성되는 것을 확인할 수 있다.In addition, Figure 1 shows the results of the appearance comparison of Example 2 and Comparative Example 5, from Figure 1, in the case of Comparative Example 5 (left) containing C18-21 alkane oil in 3% by weight fatty acid component (stearic acid) It can be confirmed with the naked eye that the formulation is not made by precipitation with the granules, while in the case of Example 2 (right) according to the present invention, it can be confirmed that the gel formulation is stably formed without precipitation of the powder component.
[시험예 3] HLB가 3 내지 6인 유화제의 함량에 따른 제형 안정도 평가[Test Example 3] Evaluation of formulation stability according to the content of emulsifier with HLB of 3 to 6
하기 표 3에 따른 조성의 수중유형 조성물을 상기 시험예 1과 동일한 방법으로 제조하고, 제형 안정도를 평가하였다. 제형 안정도는 55℃ 오븐에 각 조성물을 넣고 1주일 동안 관찰하면서 분리현상이 없으면 안정한 것으로 평가하였다. 그 결과는 하기 표 3에 나타내었다.The oil-in-water composition of the composition according to Table 3 was prepared in the same manner as in Test Example 1, and the formulation stability was evaluated. The formulation stability was evaluated by putting each composition in an oven at 55° C. and observing it for one week, so that there was no separation phenomenon and it was stable. The results are shown in Table 3 below.
(HLB: 16.7)polysorbate 20
(HLB: 16.7)
상기 표 3의 결과로부터, 본 발명에 따라 HLB가 3 내지 6인 유화제(소르비탄 스테아레이트)를 3 및 4 중량%로 포함하는 실시예 2 및 6의 경우 제형이 안정적으로 형성되는 것을 확인할 수 있었다.From the results of Table 3, it was confirmed that the formulations were stably formed in Examples 2 and 6 containing 3 and 4% by weight of an emulsifier (sorbitan stearate) having an HLB of 3 to 6 according to the present invention. .
반면, 소르비탄 스테아레이트를 포함하지 않거나, 1 중량% 및 6 중량%로 포함하는 비교예 7 내지 9의 경우에는 제형이 분리되는 것을 확인할 수 있었다.On the other hand, it was confirmed that the formulations are separated in the case of Comparative Examples 7 to 9, which does not contain sorbitan stearate or contains 1 wt% and 6 wt%.
[시험예 4] HLB가 10 내지 18인 유화제의 함량에 따른 제형 안정도 평가[Test Example 4] Evaluation of formulation stability according to the content of emulsifier with HLB of 10 to 18
하기 표 4에 따른 조성의 수중유형 조성물을 상기 시험예 1과 동일한 방법으로 제조하고, 상기 시험예 3과 동일한 방법으로 제형 안정도를 평가하였다. 그 결과는 하기 표 4에 나타내었다.The oil-in-water composition of the composition according to Table 4 was prepared in the same manner as in Test Example 1, and the formulation stability was evaluated in the same manner as in Test Example 3. The results are shown in Table 4 below.
(HLB: 16.7)polysorbate 20
(HLB: 16.7)
상기 표 4의 결과로부터, 본 발명에 따라 HLB가 10 내지 18인 유화제(폴리소르베이트 20)를 3 내지 5 중량%로 포함하는 실시예 2, 7 및 8의 경우 제형이 안정적으로 형성되는 것을 확인할 수 있었다.From the results of Table 4, it was confirmed that the formulations are stably formed in Examples 2, 7 and 8 containing 3 to 5% by weight of an emulsifier (polysorbate 20) having an HLB of 10 to 18 according to the present invention. Could.
반면, 폴리소르베이트 20를 포함하지 않거나, 1 중량% 및 6 중량%로 포함하는 비교예 10 내지 12의 경우에는 제형이 빠른 시간 내에 분리되어 제형 안정도고 좋지 않음을 확인할 수 있었다.On the other hand, in the case of Comparative Examples 10 to 12 that do not contain polysorbate 20, or contain 1 wt% and 6 wt%, it was confirmed that the formulation was separated within a short period of time and the formulation was stable and poor.
또한, 도 2는 실시예 2 및 비교예 10의 제형 안정도 평가 결과를 나타낸 것으로서, 도 2로부터, 폴리소르베이트 2를 포함하지 않는 비교예 10(오른쪽)의 경우 제형이 유화 분리되는 것을 확인할 수 있으며, 반면 본 발명에 따른 실시예 2(왼쪽)의 경우 유화 분리됨이 없이 안정적으로 제형이 형성되는 것을 확인할 수 있다.In addition, Figure 2 shows the results of the formulation stability evaluation of Example 2 and Comparative Example 10, from Figure 2, in the case of Comparative Example 10 (right) containing no polysorbate 2, it can be confirmed that the formulation is separated by emulsion, On the other hand, in the case of Example 2 (left) according to the present invention, it can be confirmed that the formulation is stably formed without being separated from the emulsion.
[시험예 5] 흡유 파우더 함량에 따른 상전이 효과 평가[Test Example 5] Evaluation of phase transition effect according to the content of oil absorption powder
하기 표 5에 따른 조성의 수중유형 조성물을 상기 시험예 1과 동일한 방법으로 제조하고, 상기 시험예 1에서와 동일한 방법으로 상전이 효과를 평가하였다. 그 결과는 하기 표 5에 나타내었다.An oil-in-water composition of the composition according to Table 5 was prepared in the same manner as in Test Example 1, and the phase transition effect was evaluated in the same manner as in Test Example 1. The results are shown in Table 5 below.
상기 표 5의 결과로부터, 본 발명에 따라 흡유 파우더(PMMA)를 17 내지 25 중량%로 포함하는 실시예 2, 9 내지 11의 경우, 제형 내 오일을 효과적으로 흡유하여 빠른 상전이 효과가 나타나는 것을 확인할 수 있었다.From the results of Table 5, in the case of Examples 2 and 9 to 11 containing 17 to 25% by weight of the oil absorption powder (PMMA) according to the present invention, it can be confirmed that the oil in the formulation is effectively absorbed and a rapid phase transition effect is exhibited. there was.
반면, PMMA를 포함하지 않거나 10 중량%로 포함하는 비교예 13 및 14의 경우 오일 흡유가 잘 이루어지지 않아 점도가 낮아지고 상전이 효과가 나타나지 않았으며, PMMA를 30 중량%로 포함하는 비교예 15의 경우에는 오일이 지나치게 많이 흡유되어 상전이 효과가 나타나지 않음을 확인할 수 있었다.On the other hand, in the case of Comparative Examples 13 and 14 that do not contain PMMA or contain 10% by weight, the oil absorption is not well done, and thus the viscosity is lowered and the phase transition effect does not appear, and that of Comparative Example 15 containing PMMA as 30% by weight In the case, it was confirmed that the oil was absorbed too much and the phase transition effect was not exhibited.
Claims (13)
피부에 도포 시 젤상(gel phase)에서 액상(liquid phase)으로의 상전이 성질을 지니는, 젤 제형의 수중유형 화장료 조성물.fatty acid; Hydrocarbon-based oils; Emulsifiers having a hydrophile-lipophile balance (HLB) of 3 to 6; Emulsifier with HLB of 10 to 18; And oil absorption powder,
An oil-in-water cosmetic composition of a gel formulation having a phase transition property from a gel phase to a liquid phase when applied to the skin.
상기 지방산은 스테아르산(stearic acid), 팔미트산(palmitic acid), 라우르산(lauric acid), 카프로산(caproic acid), 베헨산(behenic acid) 및 이들의 조합으로부터 선택되는 1종의 포화지방산; 올레산(oleic acid), 리놀레산(linoleic acid) 및 리놀레닉산(linolenic acid) 및 이들의 조합으로부터 선택되는 1종의 불포화지방산; 및 이들의 조합으로부터 선택되는 1종 이상인 것을 특징으로 하는, 젤 제형의 수중유형 화장료 조성물.According to claim 1,
The fatty acid is one saturation selected from stearic acid, palmitic acid, lauric acid, caproic acid, behenic acid and combinations thereof. fatty acid; One unsaturated fatty acid selected from oleic acid, linoleic acid and linolenic acid, and combinations thereof; And it characterized in that at least one selected from a combination of these, the oil-in-water cosmetic composition of the gel formulation.
상기 지방산은 조성물 총 중량을 기준으로 7 내지 10 중량%의 양으로 함유되는 것을 특징으로 하는, 젤 제형의 수중유형 화장료 조성물.According to claim 1,
The fatty acid is characterized in that it is contained in an amount of 7 to 10% by weight based on the total weight of the composition, oil-in-water cosmetic composition of the gel formulation.
상기 하이드로카본계 오일은 C18-21 알칸(C18-21 alkane), 이소헥사데칸(isohexadecane), 이소도데칸(isododecane), 운데칸(undecane), 스쿠알란(squalan), 스쿠알렌(squalene), 하이드로제네이티드폴리데센(hydrogenated polydecene), 하이드로제네이티드폴리이소부텐(hydrogenated polyisobutene) 및 알파올레핀올리고머(alpha olefin oligomers) 중에서 선택되는 1종 이상인 것을 특징으로 하는, 젤 제형의 수중유형 화장료 조성물.According to claim 1,
The hydrocarbon-based oil is C18-21 alkane (C18-21 alkane), isohexadecane (isohexadecane), isododecane (isododecane), undecane (undecane), squalane (squalan), squalene (squalene), hydrogenated An oil-in-water cosmetic composition of a gel formulation, characterized in that at least one selected from hydrogenated polydecene, hydrogenated polyisobutene and alpha olefin oligomers.
상기 하이드로카본계 오일은 조성물 총 중량을 기준으로 5 내지 9 중량%의 양으로 함유되는 것을 특징으로 하는, 젤 제형의 수중유형 화장료 조성물.According to claim 1,
The hydrocarbon-based oil is characterized in that it is contained in an amount of 5 to 9% by weight based on the total weight of the composition, oil-in-water cosmetic composition of the gel formulation.
상기 HLB가 3 내지 6인 유화제는 소르비탄 모노스테아레이트(sorbitan monostearate), 소르비탄 이소스테아레이트(sorbitan isostearate), 소르비탄 모노이소스테아레이트(sorbitan monoisostearate), 소르비탄 트리스테아레이트(sorbitan tristearate), 소르비탄 모노라우레이트(sorbitan monolaurate), 글리세롤 모노스테아레이트(glycerol monostearate), 글리세롤 모노올레이트(glycerol monooleate), 세틸 피이지/피피지-10/1 디메치콘(cetyl PEG/PPG-10/1 dimethicone), 피이지-30 디폴리하이드록시스테아레이트(PEG-30 dipolyhydroxystearate), 라우릴 피이지/피피지-18/18 메치콘(lauryl PEG/PPG-18/18 methicone; laurylmethicone copolyol) 및 피이지-10 디메치콘(PEG-10 dimethicone) 중에서 선택되는 1종 이상인 것을 특징으로 하는, 젤 제형의 수중유형 화장료 조성물.According to claim 1,
The HLB 3 to 6 emulsifier is sorbitan monostearate (sorbitan monostearate), sorbitan isostearate, sorbitan monoisostearate, sorbitan monoisostearate, sorbitan tristearate, Sorbitan monolaurate, glycerol monostearate, glycerol monooleate, cetyl PEG/FIG-10-10 cetyl PEG/PPG-10/1 dimethicone ), PEG-30 dipolyhydroxystearate, lauryl PEG/PPG-18/18 methicone; laurylmethicone copolyol and PEG- 10 Dimethicone (PEG-10 dimethicone), characterized in that at least one selected from, gel-type oil-in-water cosmetic composition.
상기 HLB가 3 내지 6인 유화제는 조성물 총 중량을 기준으로 3 내지 5 중량%의 양으로 함유되는 것을 특징으로 하는, 젤 제형의 수중유형 화장료 조성물.According to claim 1,
The emulsifier having 3 to 6 HLB is characterized in that it is contained in an amount of 3 to 5% by weight based on the total weight of the composition, oil-in-water cosmetic composition of the gel formulation.
상기 HLB가 10 내지 18인 유화제는 세테아레스-12(ceteareth-12), 세테아레스-20(ceteareth-20), 세테아레스-25(ceteareth-25), 세테아레스-30(ceteareth-30), 피이지-20 스테아레이트(PEG-20 stearate), 피이지-30 스테아레이트(PEG-30 stearate), 피이지-40 스테아레이트(PEG-40 stearate), 피이지-100 스테아레이트(PEG-100 stearate), 폴리소르베이트 20(polysorbate 20), 폴리소르베이트 40(polysorbate 40), 폴리소르베이트 60(polysorbate 60), 폴리소르베이트 80(polysorbate 80), 피이지-20 글리세릴 이소스테아레이트(PEG-20 glyceryl isostearate), 피이지-60 글리세릴 이소스테아레이트(PEG-60 glyceryl isostearate) 및 비스-피이지-18 메틸 에테르 디메틸 실란(bis-PEG-18 methyl ether dimethyl silane) 중에서 선택되는 1종 이상인 것을 특징으로 하는, 젤 제형의 수중유형 화장료 조성물.According to claim 1,
The emulsifier having an HLB of 10 to 18 is ceteareth-12, ceteareth-20, ceteareth-25, ceteareth-30, p PEG-20 stearate, PEG-30 stearate, PEG-40 stearate, PEG-100 stearate , Polysorbate 20, polysorbate 40, polysorbate 60, polysorbate 80, PEG-20 glyceryl isostearate (PEG-20 Features at least one selected from glyceryl isostearate, PEG-60 glyceryl isostearate, and bis-PEG-18 methyl ether dimethyl silane The oil-in-water cosmetic composition of the gel formulation.
상기 HLB가 10 내지 18인 유화제는 조성물 총 중량을 기준으로 3 내지 5 중량%의 양으로 함유되는 것을 특징으로 하는, 젤 제형의 수중유형 화장료 조성물.According to claim 1,
The HLB 10 to 18 emulsifier is characterized in that it is contained in an amount of 3 to 5% by weight based on the total weight of the composition, oil-in-water cosmetic composition of the gel formulation.
상기 HLB가 3 내지 6인 유화제 및 상기 HLB가 10 내지 18인 유화제는 중량비 3 내지 4 : 3 내지 5로 함유되는 것을 특징으로 하는, 젤 제형의 수중유형 화장료 조성물.According to claim 1,
The HLB 3 to 6 emulsifier and the HLB 10 to 18 emulsifier is characterized in that it is contained in a weight ratio of 3 to 4: 3 to 5, oil-in-water cosmetic composition of the gel formulation.
상기 흡유 파우더는 폴리메틸메타크릴레이트(polymethyl methacrylate, PMMA), 실리카, 나일론 파우더, 보론 나이트라이드 파우더, 티타늄 옥사이드, 징크 옥사이드 및 실리콘 엘라스토머 중에서 선택되는 1종 이상인 것을 특징으로 하는, 젤 제형의 수중유형 화장료 조성물.According to claim 1,
The oil absorption powder is characterized in that at least one selected from polymethyl methacrylate (PMMA), silica, nylon powder, boron nitride powder, titanium oxide, zinc oxide and silicone elastomer, the oil-in-water type of the gel formulation Cosmetic composition.
상기 흡유 파우더는 조성물 총 중량을 기준으로 17 내지 25 중량%의 양으로 함유되는 것을 특징으로 하는, 젤 제형의 수중유형 화장료 조성물.According to claim 1,
The oil absorption powder is characterized in that it is contained in an amount of 17 to 25% by weight based on the total weight of the composition, oil-in-water cosmetic composition of the gel formulation.
상기 조성물은 점도가 45,000 내지 75,000 cps인 것을 특징으로 하는, 젤 제형의 수중유형 화장료 조성물.According to claim 1,
The composition is characterized in that the viscosity is 45,000 to 75,000 cps, oil-in-water cosmetic composition of the gel formulation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190004462A KR20200088005A (en) | 2019-01-14 | 2019-01-14 | Oil-in-water cosmetic composition of gel form with phase transfer characteristics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190004462A KR20200088005A (en) | 2019-01-14 | 2019-01-14 | Oil-in-water cosmetic composition of gel form with phase transfer characteristics |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20200088005A true KR20200088005A (en) | 2020-07-22 |
Family
ID=71893078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190004462A KR20200088005A (en) | 2019-01-14 | 2019-01-14 | Oil-in-water cosmetic composition of gel form with phase transfer characteristics |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20200088005A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112741780A (en) * | 2019-10-31 | 2021-05-04 | 株式会社爱茉莉太平洋 | Phase transfer cosmetic composition |
KR102375282B1 (en) | 2021-09-07 | 2022-03-17 | 주식회사 미누스토리 | Cosmetic composition comprising Oil/IPDIcopolymer and having reversible phase transfer property when applied to the skin, and method for preparing the same |
KR20220049186A (en) * | 2020-10-14 | 2022-04-21 | 코스맥스 주식회사 | Water-in-oil type UV protection cosmetic composition for controlling skin temperature |
KR102485847B1 (en) * | 2022-01-14 | 2023-01-09 | 주식회사 한국화장품제조 | A cosmetic composition capable of changing the shape from an emulsified cream state to a mist state |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100970922B1 (en) | 2007-12-12 | 2010-07-16 | 한국콜마 주식회사 | Patch compositions being capable of phase transition at body temperature and improving skin elasticity, moisturization and drug penetration |
-
2019
- 2019-01-14 KR KR1020190004462A patent/KR20200088005A/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100970922B1 (en) | 2007-12-12 | 2010-07-16 | 한국콜마 주식회사 | Patch compositions being capable of phase transition at body temperature and improving skin elasticity, moisturization and drug penetration |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112741780A (en) * | 2019-10-31 | 2021-05-04 | 株式会社爱茉莉太平洋 | Phase transfer cosmetic composition |
CN112741780B (en) * | 2019-10-31 | 2024-02-02 | 株式会社爱茉莉太平洋 | Phase transfer cosmetic composition |
KR20220049186A (en) * | 2020-10-14 | 2022-04-21 | 코스맥스 주식회사 | Water-in-oil type UV protection cosmetic composition for controlling skin temperature |
KR102375282B1 (en) | 2021-09-07 | 2022-03-17 | 주식회사 미누스토리 | Cosmetic composition comprising Oil/IPDIcopolymer and having reversible phase transfer property when applied to the skin, and method for preparing the same |
KR102485847B1 (en) * | 2022-01-14 | 2023-01-09 | 주식회사 한국화장품제조 | A cosmetic composition capable of changing the shape from an emulsified cream state to a mist state |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20200088005A (en) | Oil-in-water cosmetic composition of gel form with phase transfer characteristics | |
KR102464015B1 (en) | Sun screening cometic composition comprising a polyglyceryl-based emulsifier and a sorbitan-based emulsifier | |
KR101898244B1 (en) | Water in oil makeup cosmetic composition as solid cream type | |
KR102070826B1 (en) | Cosmetic composition in the form of high internal phase water in silicone formulation with excellent stability | |
US11510863B2 (en) | Water-in-oil emulsion cosmetics | |
KR101507090B1 (en) | Essence cosmetic composition with high moisturing effects in gel type | |
KR102453279B1 (en) | Oil-in-water emulsion composition comprising high content silicone elastomer | |
KR102673707B1 (en) | Low viscosity cosmetic composition stabilizing solid oily components | |
KR20160065658A (en) | Emulsifier-Free Washable Cleansing Cosmetic Composition | |
KR101125922B1 (en) | Cosmetic composition with low viscosity | |
KR102453890B1 (en) | A composition for stabilizing component with ph sensitivity | |
KR100740598B1 (en) | Oil-in-water type emulsion cosmetic composition | |
KR100678790B1 (en) | Oil in water emulsion cosmetic compositions for blocking ultraviolet | |
KR102202394B1 (en) | Oil in water type sunscreen cosmetic composition comprising algin | |
KR20180003146A (en) | Cosmetic Composition Capable of Phase-Inversion on Skin | |
KR20200109175A (en) | Solid Type Sun Screening Cosmetic Composition | |
KR102058513B1 (en) | Cosmetic composition with ductility for uv protection and cosmetic comprising the same | |
KR102574547B1 (en) | Water-drop macro emulsion cosmetic composition stably containing inorganic powder and manufacturing method of the same | |
KR102163474B1 (en) | Makeup cosmetic composition with low turbidity | |
KR102321534B1 (en) | Cosmetic composition of water-in-silicone formulation for lips | |
KR102644391B1 (en) | Cosmetic composition of water-in-oil type having improved stability | |
CN114269317A (en) | W/O type emulsified cosmetic | |
KR102274296B1 (en) | Translucent cosmetic composition | |
KR102354098B1 (en) | Sherbet Type Composition for Face Washing | |
KR102483531B1 (en) | cosmetic composition with ductility |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal |